MedPath

Zinc supplementation in asthma

Phase 3
Conditions
Asthma
Respiratory - Asthma
Registration Number
ACTRN12606000149561
Lead Sponsor
Adelaide University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Persistent asthma: on 400ug of budesonide or equivalent toachieve good to moderate asthma control.

Exclusion Criteria

Prednisolone or exacerbation within 3 months :smoking in last 2 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath